Joinn Labs invests further in CITIC Securities financial products

Beijing-based JOINN Laboratories (HKEX: 6127) announced that it has invested further in CITIC Securities financial products, bringing its aggregate outstanding investment to RMB400,000,000 as of April 14, 2025. The investments consist of eight CITIC Securities Financial Products with rates between 2.05% and 5.55%. The company said the move aims to maximize the utilization of surplus cash balances without affecting operational liquidity, while achieving higher interest yields. JOINN considers the financial products to have relatively low risk exposure and shorter terms to maturity, offering better earnings than standard bank deposits. The company said it closely monitors and effectively manages the financial products.